25th Oct 2007 10:16
Beximco Pharmaceuticals Ltd25 October 2007 BEXIMCO PHARMACEUTICALS LTD. 25 October 2007 Beximco Pharma Commences Exports to Fiji Beximco Pharmaceuticals Ltd. ("BPL" or the "Company"), the leadingpharmaceutical manufacturer and the largest pharmaceutical exporter fromBangladesh, announces it has started supplying medicines to Fiji, a member ofthe Pacific Regional Trade Agreement. The first consignment of medicine from BPL to Fiji consist a number ofrespiratory care products, including metered dose inhalers and nasal sprays. Mr. Nazmul Hassan, CEO of Beximco Pharma said: "Oceania is a strategically important market for BPL. Fiji is the second countryin Oceania, after Papua New Guinea, where we have started exporting ourmedicines and commencing exports to Fiji will accelerate BPL's expansion in thisregion." For further enquiries please contact: Beximco Pharma Tel: +880 2 861 9151, ext.2080Nazmul Hassan, CEO Financial Dynamics Tel: +44 (0)20 7269 7169John Gilbert Libertas Capital Tel: +44 (0)20 7569 9650Aamir Quraishi/Andrew Hardy About Beximco Pharmaceuticals Limited Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sellsgeneric pharmaceutical formulation products, active pharmaceutical ingredientsand intravenous fluids. The Company also manufactures and markets its ownbranded generics for almost all diseases. The Company also undertakes contractmanufacturing for multinational pharmaceutical companies. The Company operatesfrom a 20 acre site in Dhaka and currently employs over 2,400 staff. The Company's products are sold to retail outlets, medical institutions andother pharmaceutical manufacturers in Bangladesh, in regional markets such asPakistan, Nepal, Bhutan, Cambodia and Myanmar and in other markets overseas,principally in East Africa and South East Asia, including Singapore. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Beximco Pharma